BR112014008657A2 - composição para o uso em aumentar a sensibilidade à insulina e/ou reduzir a resistência à insulina - Google Patents
composição para o uso em aumentar a sensibilidade à insulina e/ou reduzir a resistência à insulinaInfo
- Publication number
- BR112014008657A2 BR112014008657A2 BR112014008657A BR112014008657A BR112014008657A2 BR 112014008657 A2 BR112014008657 A2 BR 112014008657A2 BR 112014008657 A BR112014008657 A BR 112014008657A BR 112014008657 A BR112014008657 A BR 112014008657A BR 112014008657 A2 BR112014008657 A2 BR 112014008657A2
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- insulin resistance
- reducing
- increasing
- insulin sensitivity
- Prior art date
Links
- 206010022489 Insulin Resistance Diseases 0.000 title abstract 7
- 239000000203 mixture Substances 0.000 title abstract 7
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title abstract 5
- 229920001542 oligosaccharide Polymers 0.000 abstract 4
- 150000002482 oligosaccharides Chemical class 0.000 abstract 4
- 229940062827 2'-fucosyllactose Drugs 0.000 abstract 1
- HWHQUWQCBPAQQH-UHFFFAOYSA-N 2-O-alpha-L-Fucosyl-lactose Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(CO)OC1OC(C(O)CO)C(O)C(O)C=O HWHQUWQCBPAQQH-UHFFFAOYSA-N 0.000 abstract 1
- HWHQUWQCBPAQQH-BWRPKUOHSA-N 2-fucosyllactose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O HWHQUWQCBPAQQH-BWRPKUOHSA-N 0.000 abstract 1
- AXQLFFDZXPOFPO-UHFFFAOYSA-N UNPD216 Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC(C1O)C(O)C(CO)OC1OC1C(O)C(O)C(O)OC1CO AXQLFFDZXPOFPO-UHFFFAOYSA-N 0.000 abstract 1
- SNFSYLYCDAVZGP-UHFFFAOYSA-N UNPD26986 Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(OC(O)C(O)C2O)CO)OC(CO)C(O)C1O SNFSYLYCDAVZGP-UHFFFAOYSA-N 0.000 abstract 1
- AXQLFFDZXPOFPO-UNTPKZLMSA-N beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp Chemical compound O([C@@H]1O[C@H](CO)[C@H](O)[C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H]([C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O1)O)NC(=O)C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@@H]1CO AXQLFFDZXPOFPO-UNTPKZLMSA-N 0.000 abstract 1
- 208000004104 gestational diabetes Diseases 0.000 abstract 1
- IEQCXFNWPAHHQR-UHFFFAOYSA-N lacto-N-neotetraose Natural products OCC1OC(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)C(NC(=O)C)C(O)C1OC1OC(CO)C(O)C(O)C1O IEQCXFNWPAHHQR-UHFFFAOYSA-N 0.000 abstract 1
- USIPEGYTBGEPJN-UHFFFAOYSA-N lacto-N-tetraose Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC1C(O)C(CO)OC(OC(C(O)CO)C(O)C(O)C=O)C1O USIPEGYTBGEPJN-UHFFFAOYSA-N 0.000 abstract 1
- 229940062780 lacto-n-neotetraose Drugs 0.000 abstract 1
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 abstract 1
- RBMYDHMFFAVMMM-PLQWBNBWSA-N neolactotetraose Chemical compound O([C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@H]([C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@@H]1O)O)NC(=O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O RBMYDHMFFAVMMM-PLQWBNBWSA-N 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 239000006041 probiotic Substances 0.000 abstract 1
- 230000000529 probiotic effect Effects 0.000 abstract 1
- 235000018291 probiotics Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Microbiology (AREA)
- Pediatric Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
resumo patente de invenção: "composição para o uso em aumentar a sensibilidade à insulina e/ou reduzir a resistência à insulina". a presente invenção refere-se a uma composição compreendendo pelo menos um ácido graxo poli-insaturado de cadeia longa, pelo menos um probiótico e uma mistura de oligossacarídeos, a dita mistura contendo pelo menos um de lacto-n-neotetraose (lnnt) e lacto-n-tetraose (lnt), pelo menos um oligossacarídeo n-acetilado diferente de lnnt e lnt, pelo menos um oligossacarídeo sialilado e pelo menos um oligossacarídeo neutro, para o uso em aumentar a sensibilidade à insulina e/ou reduzir a resistência à insulina. esta composição opcionalmente compreende ainda 2'-fucosil lactose (fl). esta composição é particularmente adaptada para o uso em lactentes que nasceram pré-termo e/ou que experienciaram iugr, em mulheres grávidas sofrendo de diabete gestacional e em crianças, adolescentes, e adultos sofrendo de resistência à insulina e/ou diabete tipo ii.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11185603 | 2011-10-18 | ||
PCT/EP2012/070356 WO2013057061A1 (en) | 2011-10-18 | 2012-10-15 | Composition for use in increasing insulin sensitivity and/or reducing insulin resistance |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112014008657A2 true BR112014008657A2 (pt) | 2017-04-25 |
Family
ID=47046594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014008657A BR112014008657A2 (pt) | 2011-10-18 | 2012-10-15 | composição para o uso em aumentar a sensibilidade à insulina e/ou reduzir a resistência à insulina |
Country Status (13)
Country | Link |
---|---|
US (1) | US9636367B2 (pt) |
EP (1) | EP2768314B1 (pt) |
CN (1) | CN103889240B (pt) |
AU (1) | AU2012325072B2 (pt) |
BR (1) | BR112014008657A2 (pt) |
CL (1) | CL2014000832A1 (pt) |
ES (1) | ES2560023T3 (pt) |
MX (1) | MX350436B (pt) |
PL (1) | PL2768314T3 (pt) |
PT (1) | PT2768314E (pt) |
RU (1) | RU2604503C2 (pt) |
WO (1) | WO2013057061A1 (pt) |
ZA (1) | ZA201403593B (pt) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2014368585A1 (en) * | 2013-12-19 | 2016-05-19 | Nestec S.A. | Nutritional composition for use in reducing metabolic stress in infants, decreasing gut permeability and approximating growth rate of breast-fed infants |
EP3229812A4 (en) | 2014-12-08 | 2018-10-03 | Glycom A/S | Synthetic composition for treating metabolic disorders |
US10881674B2 (en) * | 2014-12-08 | 2021-01-05 | Glycom A/S | Synthetic composition for treating metabolic disorders |
US10987368B2 (en) | 2014-12-08 | 2021-04-27 | Glycom A/S | Synthetic composition for preventing or treating CVD |
US10835544B2 (en) | 2014-12-08 | 2020-11-17 | Glycom A/S | Synthetic composition for regulating satiety |
DK3349763T3 (en) | 2015-09-14 | 2021-11-15 | Glycom As | Composition for use in microbiota modulation |
CN108289492A (zh) | 2015-12-15 | 2018-07-17 | 雀巢产品技术援助有限公司 | Hmo的混合物 |
EP3854227A1 (en) * | 2016-04-11 | 2021-07-28 | Société des Produits Nestlé S.A. | Infant nutrition delivering metabolic benefits |
EP3471562A4 (en) * | 2016-06-15 | 2020-07-29 | Glycom A/S | SYNTHETIC COMPOSITIONS WITH MOTHER MILK OLIGOSACCHARIDES FOR THE PREVENTION AND TREATMENT OF DISEASES |
BR112019004405A2 (pt) | 2016-09-07 | 2020-06-23 | Temple University - Of The Commonwealth System Of Higher Education | Compostos e seus usos para aumentar a sensibilidade à insulina, reduzir a resistência à insulina e/ou prevenir a resistência à insulina e para tratar um distúrbio de resistência à insulina e composição os compreendendo |
TWI658791B (zh) * | 2017-09-25 | 2019-05-11 | 愛之味股份有限公司 | 具有調節血脂、改善腸道菌叢及提升免疫力功能的富含寡醣乳製品及其製法 |
WO2019118984A2 (en) | 2017-12-15 | 2019-06-20 | Solarea Bio, Inc. | Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome |
US11304966B2 (en) * | 2017-12-22 | 2022-04-19 | Glycom A/S | Composition comprising HMOs for preventing or reducing nociception |
JP7266580B2 (ja) * | 2018-03-23 | 2023-04-28 | 森永乳業株式会社 | 学童期以降の高血糖に起因する疾患の予防のための乳幼児用組成物 |
GB2573539A (en) * | 2018-05-09 | 2019-11-13 | Mjn Us Holdings Llc | Wellbeing supplement for postpartum maternal nutrition |
WO2020051379A1 (en) | 2018-09-05 | 2020-03-12 | Solarea Bio, Inc. | Methods and compositions for treating musculoskeletal diseases |
US11980647B2 (en) | 2018-09-05 | 2024-05-14 | Solarea Bio, Inc. | Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause |
CN113163832A (zh) * | 2018-11-30 | 2021-07-23 | 雀巢产品有限公司 | 用于增强胰腺成熟和胰岛素生物合成的婴儿营养组合物 |
CN111165825A (zh) * | 2019-07-17 | 2020-05-19 | 江苏西宏生物医药有限公司 | 一种术前经肠营养组合物 |
AU2022391767A1 (en) | 2021-11-22 | 2024-07-04 | Solarea Bio, Inc. | Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause |
US20230190834A1 (en) | 2021-12-21 | 2023-06-22 | Solarea Bio, Inc. | Immunomodulatory compositions comprising microbial entities |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5422346A (en) * | 1988-01-06 | 1995-06-06 | California Natural Products | Instant dried dahlia inulin juice and its method of production and usage |
EP0481038B1 (en) | 1990-04-16 | 2002-10-02 | The Trustees Of The University Of Pennsylvania | Saccharide compositions, methods and apparatus for their synthesis |
US5545553A (en) | 1994-09-26 | 1996-08-13 | The Rockefeller University | Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
ATE305309T1 (de) * | 2002-02-04 | 2005-10-15 | Kyowa Hakko Kogyo Kk | Pharmazeutische und lebenmittelzusammensetzungen mit einem di- oder oligosaccharid, das die insulinfreisetzung steigert |
US6942857B2 (en) * | 2002-08-09 | 2005-09-13 | Bioneer Corporation | Microorganisms for preventing and/or treating obesity or diabetes mellitus |
US20050175759A1 (en) | 2004-02-09 | 2005-08-11 | Atul Singhal | Newborn infant formulas and feeding methods |
GB0302929D0 (en) * | 2003-02-10 | 2003-03-12 | Inst Of Child Health | Nutrient composition |
SE529185C2 (sv) * | 2005-10-07 | 2007-05-22 | Arla Foods Amba | Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt |
EP1962617A2 (en) * | 2005-12-23 | 2008-09-03 | N.V. Nutricia | Infant nutritional compositions for preventing obesity |
RU2430631C2 (ru) * | 2006-02-10 | 2011-10-10 | Нестек С.А. | Пребиотическая смесь олигосахаридов и пищевой продукт, ее содержащий |
US9005682B2 (en) * | 2006-03-07 | 2015-04-14 | Nestec S.A. | Synbiotic mixture |
WO2008054193A1 (en) * | 2006-11-02 | 2008-05-08 | N.V. Nutricia | Nutritional products that comprise saccharide oligomers |
EP2011506A1 (en) * | 2007-07-05 | 2009-01-07 | Nestec S.A. | Supplementation of maternal diet |
PT2217246E (pt) * | 2007-11-08 | 2015-02-10 | Nestec Sa | Utilização de oligossacáridos contendo n-acetil-lactosamina para maturação de respostas imunes em recém-nascidos |
EP2072052A1 (en) * | 2007-12-17 | 2009-06-24 | Nestec S.A. | Prevention of opportunistic infections in immune-compromised subjects |
EP2143341A1 (en) * | 2008-07-08 | 2010-01-13 | Nestec S.A. | Nutritional Composition Containing Oligosaccharide Mixture |
BRPI1014923A2 (pt) * | 2009-04-01 | 2015-09-01 | Nestec Sa | Redução do risco de obesidade |
EP2258216A1 (en) * | 2009-06-02 | 2010-12-08 | Nestec S.A. | Nutritional Composition for Supporting Brain Development and Function of Toddlers |
-
2012
- 2012-10-15 AU AU2012325072A patent/AU2012325072B2/en active Active
- 2012-10-15 BR BR112014008657A patent/BR112014008657A2/pt active Search and Examination
- 2012-10-15 CN CN201280051320.9A patent/CN103889240B/zh active Active
- 2012-10-15 US US14/352,596 patent/US9636367B2/en active Active
- 2012-10-15 PL PL12775227T patent/PL2768314T3/pl unknown
- 2012-10-15 RU RU2014119903/13A patent/RU2604503C2/ru active
- 2012-10-15 EP EP12775227.7A patent/EP2768314B1/en active Active
- 2012-10-15 WO PCT/EP2012/070356 patent/WO2013057061A1/en active Application Filing
- 2012-10-15 ES ES12775227.7T patent/ES2560023T3/es active Active
- 2012-10-15 PT PT127752277T patent/PT2768314E/pt unknown
- 2012-10-15 MX MX2014004724A patent/MX350436B/es active IP Right Grant
-
2014
- 2014-04-04 CL CL2014000832A patent/CL2014000832A1/es unknown
- 2014-05-16 ZA ZA2014/03593A patent/ZA201403593B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2768314A1 (en) | 2014-08-27 |
AU2012325072A2 (en) | 2014-05-29 |
US20140286909A1 (en) | 2014-09-25 |
CL2014000832A1 (es) | 2014-08-22 |
RU2014119903A (ru) | 2015-11-27 |
CN103889240B (zh) | 2016-09-14 |
AU2012325072B2 (en) | 2015-12-03 |
CN103889240A (zh) | 2014-06-25 |
ZA201403593B (en) | 2016-09-28 |
WO2013057061A1 (en) | 2013-04-25 |
ES2560023T3 (es) | 2016-02-17 |
PL2768314T3 (pl) | 2016-05-31 |
RU2604503C2 (ru) | 2016-12-10 |
US9636367B2 (en) | 2017-05-02 |
PT2768314E (pt) | 2016-02-17 |
MX2014004724A (es) | 2015-02-05 |
AU2012325072A1 (en) | 2014-03-13 |
MX350436B (es) | 2017-09-06 |
EP2768314B1 (en) | 2015-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014008657A2 (pt) | composição para o uso em aumentar a sensibilidade à insulina e/ou reduzir a resistência à insulina | |
BR112014008944A2 (pt) | composição para uso no crescimento cerebral e/ou desenvolvimento cognitivo e/ou psicomotor | |
De Curtis et al. | Extrauterine growth restriction in very‐low‐birthweight infants | |
Krabbendam et al. | Relationship between DHA status at birth and child problem behaviour at 7 years of age | |
BRPI0820175B8 (pt) | uso de oligossacarídeos contendo n-acetillactosamina para maturação de respostas imunes em neonatos. | |
BRPI0513500A (pt) | uso de equivalentes de aspartato, e, composição nutricional ou farmacêutica | |
BR112017007375A2 (pt) | composição compreendendo oligossa¬carídeos fut2 dependentes e lacto-n-neotetraose para uso na promoção do desenvolvimento e da cognição cerebral | |
BR112013010021A2 (pt) | combinações farmacêuticas para o tratamento de distúrbios metabólicos. | |
BR112014008425A2 (pt) | composição para o uso na promoção de angiogênese intestinal e de absorção de nutriente e de tolerância a alimentação enteral e/ou na prevenção e/ou no tratamento de inflamação intestinal e/ou na recuperação após a lesão e a cirurgia intestinal | |
MY166945A (en) | Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof | |
BR112013029269A2 (pt) | "combinação farmacêutica para uso na melhora da tolerância à glicose em pacientes com diabetes tipo 2 e o uso da mesma". | |
BR112012013766A2 (pt) | "fórmula infantil com probióticos e componentes de membrana do glóbulo de gordura do leite" | |
NZ612504A (en) | Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents | |
BR112018013538A2 (pt) | composições compreendendo 2fl e lnnt para uso em bebês ou crianças pequenas para evitar a obesidade, ou comorbidades relacionadas, em fases posteriores da vida | |
BR112012001912A8 (pt) | Composições nutritivas que compreendem fibra e probióticos | |
BR112014009097A2 (pt) | composição para uso na promoção de crescimento de osso saudável e/ou na prevenção e/ou tratamento das doenças dos ossos | |
MY177636A (en) | Use of lactic acid bacteria to treat or prevent eczema | |
BR112014009225A2 (pt) | uso de micelas de proteína de soro de leite para crianças pequenas em risco de obesidade ou diabetes | |
BR112013025976A2 (pt) | produto alimentício a base de fruta | |
BR112014007829A2 (pt) | composição para uso na promoção de absorção de magnésio e/ou retenção de magnésio | |
BR112022022781A2 (pt) | Uso de oligossacarídeos de leite humano em composições nutricionais para melhorar desenvolvimento ósseo e/ou resistência óssea | |
BR112013028820A2 (pt) | alimento medicinal para declínio cognitivo | |
BR112014000773A8 (pt) | Composições de nicotinamida e uso terapêutico das mesmas | |
BR112017002553A2 (pt) | composição nutricional a ser usada para tratar ou prevenir condições relacionadas à gravidez | |
BR112022006999A2 (pt) | Composição contendo a2-beta-caseína para promover um temperamento melhor em mamíferos jovens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Ipc: A61K 35/745 (2015.01), A23L 33/115 (2016.01), A23L |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2483 DE 07-08-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B350 | Update of information on the portal [chapter 15.35 patent gazette] |